ArticleItalian journal of pediatrics2025
Clinical value of combined detection of serum ferritin and N-terminal pro-brain natriuretic peptide in the assessment of Kawasaki disease in children over 1 year of age.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of N-terminal probrain natriuretic peptide in predicting Kawasaki disease shock syndrome: a prospective cohort study.European journal of pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTo compare the expression levels of serum ferritin and plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) in children over 1 year with Kawasaki disease (KD) and explore the early predictive value of the combined detection of these two indicators for the occurrence of intravenous immunoglobulin (IVIG) resistance and coronary artery lesions (CALs) in KD patients.
methodsA total of 320 children over 1 year of age with KD were retrospectively studied. All participants had peripheral blood samples collected at specific times to test laboratory indicators such as serum ferritin and NT-proBNP. The patients were divided into an IVIG-resistant group and an IVIG-responsive group on the basis of the initial IVIG treatment effect. According to the results of cardiac ultrasound, the patients were divided into a CAL group and a non-CAL group. SPSS 25.0 software was used for data analysis. Receiver operating characteristic (ROC) curves were used to evaluate the early diagnostic efficacy of various indicators for IVIG resistance and CALs in KD patients.
resultsLogistic regression analysis revealed that the neutrophil percentage and duration of fever before initial IVIG were independent influencing factors of IVIG resistance in KD patients. IVIG resistance, duration of fever before initial IVIG, and serum albumin level were found to be independent influencing factors of CALs. ROC curve analysis revealed that the area under the curve (AUC) of NT-proBNP for identifying IVIG resistance in KD patients was 0.698. When the cutoff value of NT-proBNP was 419.6 pg/mL, the diagnostic efficacy for IVIG resistance in KD patients was the highest, with a sensitivity of 81.3% and a specificity of 53.0%. The ROC curve analysis revealed that the AUC of NT-proBNP combined with serum ferritin for identifying CALs in KD patients was 0.666, and the diagnostic efficiency of CALs was the highest.
conclusionsIn children over 1 year of age with KD, the level of NT-proBNP could be used as an early predictor of IVIG resistance and CALs, and the serum ferritin level could be used as an early predictor of CALs. The diagnostic efficacy of CALs can be further improved when NT-proBNP and serum ferritin are jointly detected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.